The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

Some high-risk patients died during the delay, the research team reported. 

The teams behind two new studies explored very different ways to predict severe illness or death among hospitalized COVID-19 patients. 

The latest evidence of COVID-19's cardiovascular impact on patients comes from a new imaging study published in the American Journal of Roentgenology.

The new guidelines come straight from the American College of Cardiology. 

One key finding reported by the research team was a substantial decrease in AFib readmissions. 

Researchers explored data from more than 1,300 COVID-19 patients, sharing their findings in JAMA Internal Medicine. 

Overall, researchers found, women were less likely to undergo coronary angiography, percutaneous coronary intervention and mechanical circulatory support than men.

Patients who received TAVR and PCI experienced lower rates of mortality and fewer major bleeding events than those treated with SAVR and CABG. 

The analysis, written by representatives of the American Heart Association, focused on SGLT2 inhibitors and GLP-1 receptor agonists.